
CPHI Americas 2026
06/2026 – 06/2026
Wilmington PharmaTech is a US-based Contract Research, Development and Manufacturing Organization (CRDMO) specializing in small-molecule and high-potency API development and cGMP manufacturing. Founded in 2003 and headquartered in Newark, Delaware, the company provides end-to-end services from discovery through commercial supply, including custom synthesis, process development, scale-up and analytical testing for pharmaceutical and biotech companies.

No comments available.
Leave your rating & comment